DISCOUNT ZERTIFIKAT - CARDINAL HEALTH Share Price

Certificat

DE000PZ166U0

Market Closed - Boerse Frankfurt Warrants 01:10:09 26/06/2024 am IST
55.4 EUR +0.11% Intraday chart for DISCOUNT ZERTIFIKAT - CARDINAL HEALTH
Current month+2.12%
1 month+2.44%
Date Price Change
25/24/25 55.43 +0.16%
24/24/24 55.34 -0.27%
21/24/21 55.49 +0.14%
20/24/20 55.41 +0.31%
19/24/19 55.24 -0.05%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 01:10 am IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying CARDINAL HEALTH, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PZ166U
ISINDE000PZ166U0
Date issued 06/12/2023
Cap 65 $
Last trading day 19/12/2025
Maturity 19/12/2025 (542 Days)
Parity 1 : 1
Emission price 52.62
Emission volume N/A
Payment day 29/12/2025
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 42.25 %
Sideways yield 9.338 %
Sideways yield pa 6.196 %
Outperformance point 112.6 $
Break even 59.45 €
Highest since issue 55.55
Lowest since issue 51.69
Distance Cap 38.13 $
Distance Cap %+36.97%
Max. earning 5.182
Max. earning % 9.338 %

Company Profile

Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.
Sector
-
More about the company

Ratings for Cardinal Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Cardinal Health, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
103.1 USD
Average target price
112.5 USD
Spread / Average Target
+9.06%
Consensus